Improving experimental drug success rate and accelerating clinical development are top priorities for pharmaceutical and biotech companies. Careful decision making is essential to minimize development time, manage costs and improve the probability of commercial success. Modelling and simulation (M&S) can be a very useful strategy to mitigate risks and to make better-informed decisions.

Please download this free white paper to read more.